Morishita Y, Sao H, Hansen J A, Martin P J
Fred Hutchinson Cancer Research Center, University of Washington, Seattle 98104.
J Immunol. 1989 Nov 1;143(9):2783-9.
We describe a subset of CD4+/CD3+ human T lymphocytes that demonstrated a remarkably limited TCR repertoire responding to alloantigen stimulation. These cells have been characterized previously by their granular morphology and expression of CD11b but not CD28. Whereas multiple CD28+/CD4+ alloproliferative cloned cell lines generated by culture at limiting dilution immediately after isolation from peripheral blood each had a unique TCR-beta gene rearrangement, 19 of 21 CD11b+/CD4+ clones showed identical TCR-beta, and gamma gene rearrangements. In conventional MLR, the CD11b+/CD4+ cells responded poorly after stimulation with some HLA-class II Ag, and staining with a TCR Id-specific antibody and DNA blot hybridization suggested that the responding CD11b+/CD4+ cells typically contained predominant clonal populations. Clones of CD11b+/CD4+ cells with different TCR gene rearrangements showed closely similar patterns of responses when stimulated by a panel of allogeneic PBMC, but the response pattern did not correspond to that of any known HLA-class II Ag. These findings indicate that CD11b+/CD4+ cells have a limited alloproliferative repertoire characterized by predominant recognition of a limited number of undefined determinants that appear to be expressed in association with multiple distinct HLA-class II Ag. Our results suggest that CD11b+/CD4+ cells are selected for clonal reactivity by processes distinct from those for CD28+/CD4+ cells.
我们描述了CD4⁺/CD3⁺人T淋巴细胞的一个亚群,该亚群在对同种异体抗原刺激作出反应时表现出明显有限的TCR库。这些细胞先前已通过其颗粒形态和CD11b而非CD28的表达进行了表征。从外周血分离后立即通过有限稀释培养产生的多个CD28⁺/CD4⁺同种异体增殖克隆细胞系,每个都有独特的TCR-β基因重排,而21个CD11b⁺/CD4⁺克隆中有19个显示出相同的TCR-β和γ基因重排。在传统的混合淋巴细胞反应中,CD11b⁺/CD4⁺细胞在用某些HLA-II类抗原刺激后反应较差,用TCR独特型特异性抗体染色和DNA印迹杂交表明,有反应的CD11b⁺/CD4⁺细胞通常含有主要的克隆群体。具有不同TCR基因重排的CD11b⁺/CD4⁺细胞克隆在受到一组同种异体PBMC刺激时显示出非常相似的反应模式,但反应模式与任何已知的HLA-II类抗原的反应模式都不对应。这些发现表明,CD11b⁺/CD4⁺细胞具有有限的同种异体增殖库,其特征是主要识别有限数量的未定义决定簇,这些决定簇似乎与多种不同的HLA-II类抗原相关表达。我们的结果表明,CD11b⁺/CD4⁺细胞是通过与CD28⁺/CD4⁺细胞不同的过程被选择用于克隆反应性的。